 ZUG, Switzerland and CAMBRIDGE, Mass., May 04, 2022 GLOBE NEWSWIRE -- CRISPR Therapeutics Nasdaq: CRSP, a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to participate in the 2022 Bank of America Healthcare Conference on Wednesday, May 11, 2022, at 4:40 p.m. PT. 